Showing results (831-840 of 917) with videos related to

Sort By:
Pageof 92
Journal of Chromatography. A|January 13, 2026
Analysis of mRNA multimerisation (aggregation) using non-denaturing ion-pair reversed-phase liquid chromatographyAlexandra L J Webb, Emma N Welbourne, Thomas C Minshull, et al.
Nature Biotechnology|August 10, 2000
Recombining germline-derived CDR sequences for creating diverse single-framework antibody librariesE Söderlind, L Strandberg, P Jirholt, et al.
International Journal of Obesity (2005)|June 30, 2011
Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in SwedenA Carlsson, I Kockum, B Lindblad, et al.
Science (New York, N.Y.)|April 3, 2004
The structure of the first coordination shell in liquid waterPh Wernet, D Nordlund, U Bergmann, et al.
Cell Death & Disease|August 11, 2017
BET bromodomain inhibitors synergize with ATR inhibitors in melanomaSomsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, et al.
Reproduction, Fertility, and Development|November 23, 2017
Composition of marsupial zona pellucida: a molecular and phylogenetic approachCarla Moros-Nicolás, Pascale Chevret, María José Izquierdo-Rico, et al.
Biochimica Et Biophysica Acta|August 26, 1998
Detection of threonine structural changes upon formation of the M-intermediate of bacteriorhodopsin: evidence for assignment to Thr-89X Liu, M J Lee, M Coleman, et al.
The Oncologist|September 26, 2024
A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysisLily Deland, Simon Keane, Thomas Olsson Bontell, et al.
NPJ Precision Oncology|December 2, 2025
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusionSimon Keane, Ida Sjöberg, Lily Deland, et al.
Cancer Biology & Therapy|April 6, 2021
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinibLily Deland, Simon Keane, Thomas Olsson Bontell, et al.
Pageof 92